Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,124.55
    +10.20 (+0.48%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0774
    -0.0020 (-0.18%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • dólar/libra

    1.2619
    -0.0003 (-0.03%)
     
  • USD/JPY

    151.3360
    -0.0360 (-0.02%)
     
  • Bitcoin USD

    69,916.88
    -470.38 (-0.67%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,369.44
    +201.37 (+0.50%)
     

Intuitive Surgical (ISRG) Stock Moves -0.52%: What You Should Know

Intuitive Surgical (ISRG) closed at $502.71 in the latest trading session, marking a -0.52% move from the prior day. This change was narrower than the S&P 500's 0.53% loss on the day. Meanwhile, the Dow lost 0.36%, and the Nasdaq, a tech-heavy index, lost 0.94%.

Prior to today's trading, shares of the robotic surgery system company had lost 1.35% over the past month. This has was narrower than the Medical sector's loss of 3.96% and the S&P 500's loss of 1.47% in that time.

ISRG will be looking to display strength as it nears its next earnings release, which is expected to be January 24, 2019. On that day, ISRG is projected to report earnings of $2.98 per share, which would represent year-over-year growth of 17.32%. Meanwhile, our latest consensus estimate is calling for revenue of $1.04 billion, up 16.57% from the prior-year quarter.

Investors should also note any recent changes to analyst estimates for ISRG. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.

Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.1% higher. ISRG is currently a Zacks Rank #2 (Buy).

Valuation is also important, so investors should note that ISRG has a Forward P/E ratio of 40.24 right now. For comparison, its industry has an average Forward P/E of 31.37, which means ISRG is trading at a premium to the group.

Meanwhile, ISRG's PEG ratio is currently 2.77. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. Medical - Instruments stocks are, on average, holding a PEG ratio of 2.36 based on yesterday's closing prices.

The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 93, which puts it in the top 37% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement